11 reports

Filgrastim Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Biological Therapy
  • Filgrastim
  • World
  • Demand
  • filgrastim
  • filgrastim

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by 2015 sales) used in the treatment of chemotherapy-induced febrile neutropenia. These drugs, both belonging to biotech giant Amgen, fall under...

  • Filgrastim
  • United States
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Neupogen group
  • filgrastim
  • filgrastim

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia - Pipeline Review, H2 2018, provides an overview of the Chemotherapy Induced Neutropenia (Toxicology) pipeline landscape. Chemotherapy-induced...

  • Chemotherapy
  • Filgrastim
  • United States
  • World
  • Product Initiative
  • FILGRASTIM
  • FILGRASTIM - DRUG PROFILE

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia - Pipeline Review, H1 2018, provides an overview of the Chemotherapy Induced Neutropenia (Toxicology) pipeline landscape. Chemotherapy-induced...

  • Chemotherapy
  • Filgrastim
  • United States
  • World
  • Product Initiative
  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE

Neutropenia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia - Pipeline Review, H1 2018, provides an overview of the Neutropenia (Hematological Disorders) pipeline landscape. Neutropenia is an abnormally low...

  • Filgrastim
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Filgrastim: Biosimilar Products in South Korea
  • Filgrastim: Biosimilar Products in China & Taiwan - 1/2

Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis describes product portfolios and...

  • Biosimilar
  • Filgrastim
  • G-CSF
  • United States
  • Amgen Inc.
  • Target
  • Clinical Trial profile. 278 Trial Title

Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Leukocyte Disorders (White Blood Cell Disorders) Global Clinical Trials Review, H2, 2017" provides an overview of Leukocyte Disorders (White Blood Cell Disorders)...

  • Blood Disease
  • Chemotherapy
  • Clinical Trial
  • Filgrastim
  • World
  • Official Title
  • Official Title

Neutropenia Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2018" provides an overview of Neutropenia clinical trials scenario.This report provides top line data relating to the clinical trials on Neutropenia. Report...

  • Blood Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Filgrastim
  • World
  • filgrastim alone or in combination has the highest number of neutropenia ongoing clinical trials.
  • Clinical Trial profile. 13 Trial Title

Neutropenia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H2, 2016" provides an overview of Neutropenia clinical trials scenario. This report provides top line data relating to the clinical trials on Neutropenia. Report includes an overview...

  • Blood Disease
  • Filgrastim
  • Therapy
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 37 Trial Title

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2017" provides an overview of Chemotherapy Induced Neutropenia clinical trials scenario. This report provides top line data relating...

  • Chemotherapy
  • Filgrastim
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 153 Trial Title

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## pegfilgrastim alone or in combination has the highest number of febrile neutropenia ongoing clinical trials.

  • Chemotherapy
  • Clinical Trial
  • Filgrastim
  • World
  • Product Initiative